May 13, 2025 - 01:58

The United States is reconsidering its approach to restrictions on AI chip exports, a move that could significantly impact the technology landscape. Ankur Crawford, Executive Vice President and portfolio manager at Alger, emphasized the need for the US to acknowledge the competitive environment surrounding companies like Nvidia. During an insightful discussion on "Bloomberg Technology," Crawford shared her strategies for navigating investment opportunities in light of these potential policy changes.
As the US government evaluates its stance on chip curbs, the implications for the semiconductor industry and global markets are profound. The reassessment comes at a time when competition in the AI sector is intensifying, with various companies vying for dominance. Crawford's insights highlight the importance of recognizing that Nvidia is not operating in a vacuum and that other players are emerging in the field.
This shift in policy could open new avenues for investment and innovation, reshaping the dynamics of the AI chip market and influencing the broader technology sector.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...